RVMD – Revolution Medicines, Inc.
Float Short %
7.87
Margin Of Safety %
Put/Call OI Ratio
0.82
EPS Next Q Diff
-0.03
EPS Last/This Y
-1.96
EPS This/Next Y
-0.99
Price
101.82
Target Price
121.94
Analyst Recom
1
Performance Q
44.28
Upside
-166.1%
Beta
0.99
Ticker: RVMD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | RVMD | 117.69 | 0.47 | 0.18 | 114772 |
| 2026-01-26 | RVMD | 97.65 | 0.46 | 0.60 | 116959 |
| 2026-01-27 | RVMD | 99.62 | 0.46 | 1.68 | 122361 |
| 2026-01-28 | RVMD | 97.36 | 0.45 | 0.55 | 118460 |
| 2026-01-29 | RVMD | 98.21 | 0.45 | 0.10 | 120367 |
| 2026-01-30 | RVMD | 96.92 | 0.43 | 0.47 | 124889 |
| 2026-02-02 | RVMD | 97.16 | 0.43 | 3.50 | 125034 |
| 2026-02-03 | RVMD | 96 | 0.46 | 4.63 | 128711 |
| 2026-02-05 | RVMD | 96.16 | 0.49 | 1.81 | 131390 |
| 2026-02-09 | RVMD | 96.75 | 0.51 | 19.89 | 137576 |
| 2026-02-10 | RVMD | 95.88 | 0.61 | 17.26 | 147568 |
| 2026-02-11 | RVMD | 97.63 | 0.69 | 0.28 | 154824 |
| 2026-02-12 | RVMD | 97.24 | 0.72 | 0.37 | 157664 |
| 2026-02-13 | RVMD | 96.21 | 0.72 | 0.09 | 158724 |
| 2026-02-17 | RVMD | 100.6 | 0.71 | 7.28 | 160031 |
| 2026-02-18 | RVMD | 99.78 | 0.75 | 2.56 | 164984 |
| 2026-02-19 | RVMD | 102.64 | 0.76 | 0.94 | 166748 |
| 2026-02-20 | RVMD | 101.74 | 0.82 | 0.21 | 172812 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | RVMD | 117.63 | -39.8 | -250.6 | -5.54 |
| 2026-01-26 | RVMD | 97.71 | -39.8 | -25.4 | -5.54 |
| 2026-01-27 | RVMD | 99.77 | -39.8 | -293.9 | -5.54 |
| 2026-01-28 | RVMD | 97.33 | -39.8 | -228.9 | -5.54 |
| 2026-01-29 | RVMD | 98.20 | -39.8 | -277.3 | -5.54 |
| 2026-01-30 | RVMD | 96.93 | -39.8 | -245.9 | -5.54 |
| 2026-02-02 | RVMD | 97.16 | -39.8 | -268.8 | -5.54 |
| 2026-02-03 | RVMD | 95.94 | -39.8 | -246.6 | -5.54 |
| 2026-02-04 | RVMD | 96.46 | -39.8 | -271.1 | -5.54 |
| 2026-02-05 | RVMD | 96.13 | -39.8 | -259.0 | -5.54 |
| 2026-02-06 | RVMD | 97.46 | -39.8 | -284.6 | -5.54 |
| 2026-02-09 | RVMD | 96.75 | -39.8 | -253.7 | -5.54 |
| 2026-02-10 | RVMD | 95.78 | -39.8 | -250.3 | -5.54 |
| 2026-02-11 | RVMD | 97.97 | -39.8 | -294.5 | -5.54 |
| 2026-02-12 | RVMD | 97.34 | -39.8 | -255.5 | -5.54 |
| 2026-02-13 | RVMD | 96.19 | -39.8 | -247.8 | -5.54 |
| 2026-02-17 | RVMD | 100.56 | -39.2 | -327.2 | -5.54 |
| 2026-02-18 | RVMD | 99.79 | -39.2 | -253.3 | -5.54 |
| 2026-02-19 | RVMD | 102.66 | -39.2 | - | -5.54 |
| 2026-02-20 | RVMD | 101.82 | -39.2 | - | -5.54 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | RVMD | -1.66 | 2.01 | 9.26 |
| 2026-01-26 | RVMD | -1.66 | 2.06 | 9.26 |
| 2026-01-27 | RVMD | -1.66 | 2.06 | 9.26 |
| 2026-01-28 | RVMD | -1.66 | 2.06 | 8.60 |
| 2026-01-29 | RVMD | -1.66 | 2.06 | 8.60 |
| 2026-01-30 | RVMD | -1.66 | 2.06 | 8.60 |
| 2026-02-02 | RVMD | -1.66 | 2.00 | 8.60 |
| 2026-02-03 | RVMD | -1.66 | 2.00 | 8.60 |
| 2026-02-04 | RVMD | -1.66 | 2.00 | 8.60 |
| 2026-02-05 | RVMD | -1.66 | 2.00 | 8.60 |
| 2026-02-06 | RVMD | -1.66 | 2.00 | 8.60 |
| 2026-02-09 | RVMD | -1.66 | 2.99 | 8.60 |
| 2026-02-10 | RVMD | -1.66 | 2.99 | 8.60 |
| 2026-02-11 | RVMD | -1.66 | 2.99 | 7.91 |
| 2026-02-12 | RVMD | -1.66 | 2.99 | 7.91 |
| 2026-02-13 | RVMD | -1.66 | 2.99 | 7.91 |
| 2026-02-17 | RVMD | -1.66 | 3.89 | 7.91 |
| 2026-02-18 | RVMD | -1.66 | 3.89 | 7.91 |
| 2026-02-19 | RVMD | -1.71 | 3.89 | 7.87 |
| 2026-02-20 | RVMD | -1.71 | 3.89 | 7.87 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.61
Avg. EPS Est. Current Quarter
-1.6
Avg. EPS Est. Next Quarter
-1.64
Insider Transactions
-1.71
Institutional Transactions
3.89
Beta
0.99
Average Sales Estimate Current Quarter
2
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
6
Growth Score
22
Sentiment Score
71
Actual DrawDown %
18.2
Max Drawdown 5-Year %
-70.6
Target Price
121.94
P/E
Forward P/E
PEG
P/S
P/B
12.1
P/Free Cash Flow
EPS
-5.18
Average EPS Est. Cur. Y
-5.54
EPS Next Y. (Est.)
-6.53
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.51
Return on Equity vs Sector %
-89.2
Return on Equity vs Industry %
-71.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
Revolution Medicines, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 809
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading